Lampiran SPO Pengelolaan Obat LASA (Revisi Tall Man Letter)-English

LAMPIRAN SPO PENGELOLAAN OBAT LASA

I. DAFTAR DAFTAR OBAT OBAT LASA LASA (LOOKS (LOOKS ALIKE ALIKE SOUNDS ALIKE) ALIKE) AT ATAU NORUM NORUM (NAMA OBAT RUPA DAN UCAPAN MIRIP) DI RSUP DR KARIADI

TULISAN MIRIP

1 2 3 " % & + ,  1/ 1 2 3 " % & 1 2 3 " % & + ,  1/ 11 12 13 1"

1 2 3

AmiNOFILIN AmiTRIPTILIN Asam MEFENamat Asam TRANEKSamat CPZ (CHLORPROMAZi!) CBZ (CARBAMAZEPi!) THP (t#iHE$IPHENIDIL) TFP (t#iFLUOPERAZIN) FOSE FUSO L!'KIN L!'*ORIN TAR C. TOR   L-!M C-!IN Ata#OC Ata#A$ IERSON ITERSUN PENGUCAPAN MIRIP (SOUNDS ALIKE) C. $it#0 Sit# D$ORUBICIN DCETERE H!m0 H'ma0 SimARC S!mA$ ZOM!ta *OM!ta IERSON ITERSUN KEMASAN MIRIP (LOOKS ALIKE) A#masi ta Z0t ta C!- T#4i C!- E#is!0 C!- Ca#4i C!- Tim0 C!- C5!# C!- *asa6 C!- P0i-!7 C!- P0i!0 C!- L8t!!#s C!- Cata#0!s Ca#t!m ta Cata0am ta9 Aa#ai0 ta D!7am!tas am4'0 (I-a#ma) Raiti-i am4'0 (H!74:a#m) Fa##mi ta Fa#s#i- % m ta F#imaia 2// m ta Bam!t0 2// m ta M!#04am 2 m ta St!0si % m; Sa-!4#i0 %/ m ta Pa7's 3/ m i< B0!6i 1% m i< P:8tm!a-i am4'0 (P:a4#s) E4i!4:#i! (P:a4#s) T#ia Ca#4i T!t!s mata T#ia Tim0 t!t!s mata DOSIS BERBEDA LASA 1 LASA 2 LASA 3 "=EPEEDO=1/ M>

"=EPEEDO=%/ M>

IN?(EPIRUBICIN) ACTOS 1% M> TAB

IN?(EPIRUBICIN) ACTOS 3/ M>

(PIO>LITAZONE) ALBUMAN 2/@ %/ ML

(PIO>LITAZONE) ALBUMAN 2/@ 1// ML

" % &

INF ALPRAZOLAM /.% M> TAB AMLODIPINE % M> TAB AZITHROMCIN 2%/ M>

INF ALPRAZOLAM 1 M> TAB AMLODIPINE 1/ M> TAB AZITHROMCIN %// M>

TAB BENZATIN PENISILIN 192

TAB BENZATIN PENISILIN 29"

?UTA IN?. BLOPRESS , M> TAB

?UTA IN?. BLOPRESS 1& M> TAB



(CANDESARTAN) CAPTOPRIL 129% M> CASODE$

(CANDESARTAN) CAPTOPRIL 2% M> TAB

1/

(BICALUTAMIDE) %/ M>

+ ,

11

TAB CEFADRO$IL 2%/ M>

12

CAP CISPLATIN 1/ M> IN?

13

CLINDAMCINE 1%/ M>

1"

CLOZAPINE 2% M> TAB

1%

DIAMICRON MR 3/ M>

1&

DURO>ESIC 12.% MU

1+

ELO$ATIN AUEOUS

1, 1

SOL %/ M> 1/ ML IN? ENDO$AN IN? 2// M> E$?ADE 2%/ M> TAB

2/

FARSORBID % M> (ISDN)

21 22 23 2" 2% 2&

CASODE$ 1%/ M> TAB(BICALUTAMIDE) CEFADRO$IL %// M> CAP CISPLATIN %/ M> IN? CLINDAMCIN 3// M> CAPSUL CLOZAPINE 1// M> TAB DIAMICRON MR &/ M> TAB DURO>ESIC MATRI$ 2% MU ELO$ATIN AUEOUS

FENOFIBRATE 1// M> CAP FRIMANIA 2// M> TAB >ADO*IST % ML >EMCIKAL 2// M>

CAP FRIMANIA "// M> TAB >ADO*IST +9% ML >EMCIKAL 1/// M> IN?

IN?(>EMCITABINE HCL)

(>EMCITABINE) >LIMEPIRIDE 2 M> TAB9

>LBOTIC 2%/ M> IN? (AMIKACIN)

2+

HEMAPO IN? 3/// IUML

2, 2 3/

INTE>RILIN IN? 1/ ML IOMERON "// %/ ML IOPAMIRO 3// %/ ML

MU

SOL 1// M>2/ ML ENDO$AN 1 >R IN? E$?ADE %// M> TAB FARSORBID 1/ M> (ISDN) FENOFIBRATE 3// M>

>LIMEPIRIDE 1 M> TAB

DURO>ESIC MATRI$ %/

>LIMEPIRIDE 3 M> TAB >LBOTIC %// M> IN? (AMIKACIN) HEMAPO IN? 1//// IUML INTE>RILIN IN? 1// ML IOMERON "//  1//ML IOPAMIRO 3//  1// ML

>LIMEPIRIDE " M> TAB

31 32 33 3" 3% 3&

3+

3, 3 "/ "1 "2 "3

IRBESARTAN 1%/ M>

IRBESARTAN 3// M>

TAB IRINOTECAN HCL "/

TAB IRINOTECAN HCL

M>2 ML IN? ISOTIC ADRETOR /.2%@

1//M> %ML IN? ISOTIC ADRETOR /.%@

TM (TIMOLOL) LO*ENO$ "/ M> IN?.

TM (TIMOLOL)

(ENO$APARINE) MABTHERA 1// M> IN?(RITU$IMAB) METFORMIN %// M> TAB METHLPREDNISOLON " M> TABLET

LO*ENO$ /9& IN?EKSI MABTHERA %// M> IN? METFORMIN ,%/ M> TABLET METHLPREDNISOLON

METHLPREDNISOLONE

, M> TABLET

1& M> TAB

METHLPREDNISOLONE

METHLPREDNISOLONE

IN? 12% M> MICARDIS "/ M> TAB

%// M> IN? MICARDIS ,/ M> TAB

(TELMISARTAN)  NATRIUM DICLOFENAC

 NATRIUM DICLOFENAC

2% M>  NITROKAF RETARD 29%

%/ M>  NITROKAF RETARD

M> OMNIPAUE 3//  1//

FORTE % M>

ML ONDANSETRON " M>

OMNIPAUE 3%/  1// ML ONDANSENTRON , M>

IN? O$ALIPLATIN ACTA*IS

IN? O$ALIPLATIN ACTA*IS

"%

%/ M> IN? PACLITA$EL 3/ M> IN?

"&

PE> INTRON IN? ,/ MC>

1// M> IN? PACLITA$EL 1// M> IN? PE> INTRON IN? 1//

PE> INTRON PEN IN? 12/

MC>

MC>

""

"+ ", " %/ %1 %2 %3 %" %% %&

PE>ASS PFS 13% MC>

PE>ASS 1,/ MC> IN?

IN? RAMIPRIL 2.% M> TAB RISPERIDONE 1 M> TAB SALBUTAMOL 2 M> TAB SANDIMUN NEORAL 2%

RAMIPRIL % M> TAB RISPERIDONE 2 M> TAB SALBUTAMOL " M> TAB SANDIMUN NEORAL 1//

M> SERETIDE DISKUS 1// SEROUEL 1// M> TAB SIFROL /.3+% M> TAB SINDA$EL 3/ M> IN? SPIRONOLACTONE 2%

M> CAP SERETIDE DISKUS 2%/ SEROUEL 2// M> TAB SIFROL /.+% M> TAB SINDA$EL 1// M> IN? SPIRONOLACTONE 1//

M> TAB SMBICORT ,/".% U>

M> TAB SMBICORT TURB 1&/

%,

TURBUHALER  TANAPRESS % M> TAB

%

TAPROS IN? 1.,, M>

DOS 12/ TANAPRESS 1/ M> TAB TAPROS IN? 3.+% M>

&/

TRILAC IN? 1/ M>

&1 &2 &3 &" &%

ULTRA*IST 3// %/ ML *INCRISTIN 1 M> *ISIPAUE 32/%/ ML *ITAMIN A &/// *ITAMIN C 2% M> TAB $ARELTO

&&

(RI*ARO$ABAN) 1/ M>

%+

TAB ZINNAT TAB 2%/

TAPROS IN? 11.2%M> (3 M DEPOT)

TRILAC IN? "/ M> (TRIAMCINOLON) ULTRA*IST 3+/ = 1// ML *INCRISTIN 2 M> IN? *ISIPAUE 32/  1// *ITAMIN A 2//// *ITAMIN C %/ M> $ARELTO (RI*ARO$ABAN) 1% M> ZINNAT TAB %//

&+

M>(CEFURO$IME

M>(CEFURO$IME

&,

A$ETIL) ZOLADE$ IN? 3.& M>

A$ETIL) ZOLADE$ 1/., M> IN?

$ARELTO 2/ M> TAB

II. LABEL OBAT LASA

III. LABEL OBAT LASA BEDA DOSIS ('t' -it!m4!0a 4a-a at 8a m!mi0ii 0!i: -a#i sat' !'ata -sis -a t!#6at'm 4a-a -ata# at LASA9 misa08a B!Gati P!isi0i 192 <'ta I< -a B!Gati P!isi0i 29" <'ta I<). Oat LASA 8a m!mi0ii !'ata -sis 4a0i #!-a: -i!#i 0a!0 LASA 19 -sis 0!i: tii 0ai -i!#i 0a!0 LASA 29 s!-aa 8a t!#tii a-a0a: LASA 3. Bi0a :a8a m!mi0ii -'a !'ata -sis9 maa 6''4 -i'aa 0a!0 LASA 1 -a LASA 2.